Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Rentschler Biopharma and Vetter, two globally operating Contract Development and Manufacturing Organizations (CDMOs), announced that their strategic collaboration has taken key steps forward.
read more
Syneos Health® has expanded its relationship with Komodo Health.
read more
Clinical Ink has announced the hiring of CCO Chris Crucitti, COO Brian Donahue, and VP Project Operations Bill Barrasso.
read more
Flywheel and Imbio have partnered to accelerate lung disease discovery, diagnosis, and treatment in the Life Sciences.
read more
BioAscent has appointed Dr. Angelo Pugliese as Associate Director of In SilicoDiscovery and Data Analysis to lead the company’s computational chemistry service.
read more
AIXIAL, the CRO of ALTEN Group, has announced the acquisition of UK headquartered CMED Group by ALTEN EUROPE.
read more
Pete Leland, a 20-year veteran of the biotechnology industry, has joined Genovac Antibody Discovery, Fargo, N.D., as its vice president of production and characterization.
read more
CN Bio announced that the FDA has extended their research collaboration, for a further three years.
read more
Covance’s CEO Paul Kirchgraber, M.D. has released a letter regarding the company’s name change.
read more
Clean Biologics has announced the acquisition of Biodextris Inc, a Contract Development and Manufacturing Organization (CDMO) based in Laval (Montreal), Canada.
read more
Deloitte has announced its acquisition of Iperion Life Sciences Consultancy.
read more
Elligo Health Research has announced its partnership with N. Harris Computer Corporation through its Sidus Insights, Inc. subsidiary.
read more
Vectura and Inspira Pharmaceuticals have announced an agreement to develop an inhaled formulation of Inspira’s lead drug candidate for the potential treatment of COVID-19.
read more
Integrated drug discovery and pre-clinical solutions provider, Sygnature Discovery, has appointed Dr. David Lustig to the role of Vice President Business Development - United States.
read more
Lonza has announced significant investments to expand its mammalian drug substance manufacturing facilities in Visp (CH) and Portsmouth (US).
read more